| AKI patients | n available | Healthy controls | n available | T-test P | ANOVA P†| Wilcoxon rank P |
---|---|---|---|---|---|---|---|
Urine kallikrein (U/gm creatinine) | 6.74 ± 1.92 | 18 | 0.63 ± 0.08 | 37 | 0.0058 | 0.00029 | 0.0012 |
Urine aldosterone (pg/mg creatinine) | 9269.9 ± 2652.31 | 16 | 12982.4 ± 2619.78 | 38 | 0.325 | 0.65 | 0.1282 |
Urine epinephrine (ng/mg creatinine) | 20.1 ± 2.4 | 14 | 7.48 ± 1.07 | 32 | 1.11E-06 | 0.00016 | 1.79E-05 |
Urine norepinephrine, (ng/mg creatinine) | 37.15 ± 8.14 | 14 | 26.85 ± 3.2 | 32 | 0.344 | 0.16 | 0.4424 |
Urine kallikrein/urine aldosterone ratio (mU/μg) | 872.0 ± 277.5 | 15 | 160.5 ± 76.7 | 38 | 0.00027 | 8.45E-05 | 3.62E-05 |
Urine kallikrein/urine epinephrine ratio (mU/ng) | 0.32 ± 0.13 | 13 | 0.18 ± 0.04 | 31 | 0.8465 | 0.8 | 0.899 |